This content is machine translated MACE risk, heart failure incidence and all-cause mortality Metabolic syndrome as a cardiovascular risk factor Current data from 2025/2026 show: 1.54 billion adults worldwide are affected – and the risk of serious cardiovascular events increases in proportion to the number of components. New evidence on...…
View Post 9 min This content is machine translated Cardiology Minimally invasive – the quiet triumph of modern heart surgery The median sternotomy was the standard approach for cardiac surgery for many decades. With the advent of minimally invasive procedures, the guiding question of cardiac surgery shifted: away from maximum...… CME-Test
View Post 10 min This content is machine translated Patients with leg swelling DVT and other common DDs with peripheral edema Swelling of the lower extremities is common, especially in older adults. Due to the complex interrelationships, the clarification of such findings in general practice is a challenge. The differential diagnostic...…
View Post 5 min This content is machine translated Atrial fibrillation Anticoagulation after catheter ablation – for how long? In selected groups of patients with atrial fibrillation, ablation can lead to an improvement in symptoms and/or prognosis. To avoid complications, anticoagulation before, during and after ablation should be criteria-driven....…
View Post 6 min This content is machine translated Treatment of type 2 diabetes: paradigm shift continues Cardiorenal organ protection is increasingly coming to the fore Nowadays, the improvement of the cardiorenal prognosis in patients with type 2 diabetes is largely independent of the current metabolic situation. The focus of patient-oriented treatment is on quality of...…
View Post 4 min This content is machine translated Semaglutide and tirzepatide in HFpEF and T2D/obesity Prospect of improved cardiovascular prognosis Patients suffering from heart failure with preserved ejection fraction (HFpEF) are very often also affected by cardiometabolic comorbidities such as obesity and type 2 diabetes. Although previous randomized trials suggest...…
View Post 9 min This content is machine translated Omega-3 fatty acids for obesity and type 2 diabetes More fish oil for better lipid and HbA1c levels Omega-3 fatty acids have an anti-inflammatory and adipogenic effect in adipose tissue. They offer systemic benefits in metabolic and chronic inflammatory diseases. By modulating inflammation and improving insulin sensitivity, they...…
View Post 5 min This content is machine translated SGLT2 inhibitors Clear, simple language improves patient safety Sodium-glucose cotransporter 2 inhibitors (SGLT2i) were initially indicated as blood glucose-lowering drugs for type 2 diabetes. They are now widely used as first-line therapies for various indications, particularly heart failure...…
View Post 6 min This content is machine translated Recognize CKD early and avoid dialysis Screen diabetics and hypertensive patients regularly and use modern therapies High blood pressure and diabetes are the main causes of CKD – early diagnosis and treatment can reduce the risk of kidney failure and cardiorenal complications. Regular screening of these...…
View Post 5 min This content is machine translated Gestational diabetes Significant CVD prevention through five lifestyle factors Cardiovascular disease (CVD) is a major cause of morbidity and mortality in women worldwide, particularly those with adverse pregnancy outcomes such as gestational diabetes (GD). Although GD is an established...…
View Post 15 min This content is machine translated Pulmonary hypertension PH and lung diseases Pulmonary hypertension (PH) describes a hemodynamic condition with a pathological increase in pressure in the pulmonary vascular circulation. Clinically, PH causes reduced performance, shortness of breath, angina and syncope. Comprehensive...… CME-Test
